Can antibodies keep HIV in check without daily pills?

NCT ID NCT06031272

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether two lab-made antibodies can safely control HIV in people who stop their regular antiretroviral therapy for a short time. Thirty-two adults in Sub-Saharan Africa who are currently on HIV treatment will receive either the antibodies or a placebo. The goal is to see if the antibodies can keep the virus suppressed and are safe to use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aurum Institute Klerksdorp CRS (30325)

    Klerksdorp, North West, South Africa

  • Blantyre CRS (30301)

    Blantyre, Malawi

  • CAPRISA eThekwini CRS (31422)

    Durban, KwaZulu-Natal, 4011, South Africa

  • Gaborone CRS (12701)

    Molepolole, Botswana

  • Groote Schuur HIV CRS (31708)

    Cape Town, Western Cape, 7925, South Africa

  • Lilongwe Malawi CRS (12001)

    Lilongwe, Malawi

  • Rustenburg CRS (31684)

    Rustenburg, North West, 0300, South Africa

  • Soweto HVTN CRS (30351)

    Soweto, Gauteng, 1862, South Africa

  • Ward 21 CRS (31966)

    Johannesburg, Gauteng, 2001, South Africa